BlogHeader.png

Alcami RTP Expansion Nears Completion

505(b)(2): What You Need to Know

Roundtable Discussion with Pharma's Almanac: Greatest Drug Molecules to Impact Society & the Pharmaceutical Industry

Reducing Risk with Abuse‑Deterrent Formulations

Alcami Appoints Walter J. Kaczmarek III as Chief Executive Officer

Alcami Continues to Strengthen Senior Leadership Team with Appointment of Quality and Regulatory Leaders

Alcami Appoints EVP of Drug Product Operations and VP of Laboratory Operations

Component Selection Equates to Successful Sterile Fill-Finish Manufacturing

Alcami Announces Senior Leadership Appointments

Successful Methods for Obtaining Orphan Drug Approval

Alcami Supporting Potential COVID-19 Treatment

Editorial: Challenge Accepted! Problem-Solving Examples for Packaging Dilemmas

Special Feature Editorial: Outsourcing Analytical Testing - Novel Services Elicit Consistent, Quantifiable, & Faster Results

Editorial: High-Potency APIs -- Engineered for Safety

The Benefits of Establishing a Full-Time Equivalent (FTE) Program with Your Contract Service Provider

Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services

Alcami Announces Sale of its Weert, Netherlands Facility

SCIENTIST SPOTLIGHT: December 2019

Alcami Corporation Expanding Operations in Charleston County

SCIENTIST SPOTLIGHT: November 2019

Alcami Featured in Wisconsin Biohealth Industry Profile

The Importance of Secondary Packaging

SCIENTIST SPOTLIGHT: October 2019

Alcami Launches New Rapid Sterility Testing Services

ON-DEMAND WEBINAR: Alcami Introduces Rapid Sterility

Editorial: The Changing R&D Landscape

Editorial: How to Find Your Secret Source

Editorial: Considerations for Approval of Biosimilars

eBook: Analytical Testing in Drug Development

Alcami and Wisconsin Department of Natural Resources Enter Third Year of Environmental Stewardship Program

Video: High-Potency APIs

Video: Animal Health

A 3-Minute Introduction To Rapid Sterility Testing

SCIENTIST SPOTLIGHT: July 2019

Introduction to Quality by Design

Case Study: Abeona Therapeutics

SCIENTIST SPOTLIGHT: June 2019

Editorial: Enabling Technologies Advance Poorly Soluble Highly Potent APIs

Regulatory Requirements for Early Phase Drug Product Development

Editorial: Designing a CMC Strategy for Accelerated Development of Biotherapeutics

Editorial: Novel Therapies Roundtable Discussion

SCIENTIST SPOTLIGHT: May 2019

Alcami Pays Tribute to Fallen Patriots this Memorial Day

Alcami Supports Homestead High School’s Varsity Robotics Club

Stability: Top Testing Factors You Should Consider

Alcami and Students 2 Science Inspire Future Scientists

SCIENTIST SPOTLIGHT: April 2019

Alcami St. Louis Facility Issued European Medicines Agency Certification

Editorial: Overcoming the Opioid Overdose Crisis

Alcami Celebrates Earth Day with Community Cleanups

White Paper: Structural Characterization of Biologics Using High-Resolution Mass Spectrometry

Understanding Biologics: Your Top 7 Questions Answered

Video: Extractables and Leachables

SCIENTIST SPOTLIGHT: March 2019

eBook: Elemental Impurities

ON-DEMAND WEBINAR: The Importance of Microbial In-Use Studies

Editorial: An Interview with Alcami

ON-DEMAND WEBINAR: Early Phase Development of Biologics

Editorial: Oral Solids Endure & Evolve

Editorial: HPAPIs - A CDMO View

Connect Faster: Introducing Alcami RightNow™

SCIENTIST SPOTLIGHT: February 2019

Beyond the Bench: UNC Wilmington Classroom to cGMP Laboratories

Staying Ahead of OSD Challenges

SCIENTIST SPOTLIGHT: January 2019

Editorial: Outsourcing Analytical Testing - The Gateway to Drug Manufacturing

Editorial: A Practical Approach to Extractables & Leachables

The Top Five Most Asked Extractables and Leachables (e&l) Questions Answered

SCIENTIST SPOTLIGHT: December 2018

Video: Alcami's Oral Solid Dose Manufacturing

PART II: HPAPI Market Forecasts and Manufacturing Challenges

Agency-Accepted Testing and Filing Strategy for Elemental Impurities

SCIENTIST SPOTLIGHT: November 2018

Alcami STEAM Outreach Efforts Aim to Inspire Students, Advance Workforce

PART I: HPAPI Market Forecasts and Manufacturing Challenges

Case Study: Medicines Development for Global Health

The Top 8 Most Asked Questions about Microbial In-Use Studies

White Paper: Insight into Orphan Drug Formulations and Regulations

Alcami Employee Recognized with Honor Flight

Beyond the Label: Four Challenges to Serialization

SCIENTIST SPOTLIGHT: October 2018

Important Steps for Quota, Import, and Export Processes for DEA Controlled Substances

Alcami Helps Medicines Development for Global Health Secure FDA Approval of Moxidectin for River Blindness

Editorial: Aligning with Sponsors for Strategic Growth

Case Study: Stability When You Need it Most

SCIENTIST SPOTLIGHT: September 2018

ON-DEMAND WEBINAR: Extractables & Leachables 101: The Past, Present, and Future

Alcami and UNCW Awarded Biomanufacturing Workforce Development Grant

SCIENTIST SPOTLIGHT: August 2018

White Paper: Optimizing HPAPI Manufacturing Performance

Formulating for Orphan Indication Drug Products

ON-DEMAND WEBINAR: Balancing HPAPI Control with the Chemistry and Efficiency Needs of a CDMO

Considerations for Abuse-Deterrent Category One Syringeability Studies

The Role of Full Time Equivalent (FTE) Programs

Alcami Renews Partnership with Wisconsin Department of Natural Resources to Revitalize State Trails

ON-DEMAND WEBINAR: Successful Application of the New Elemental Impurities Regulation

Editorial: High-Resolution Mass Spectrometry - A Map to Biologics

Editorial: The role of DoE in early phase development

Alcami Announces Donation to Wilmington, North Carolina Fire Department

Alcami’s Extended Workbench Supports Commercial Supply of Flexion Therapeutics’s ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)

Case Study: Implementing Serialization

Alcami to Become Industry Leading Platform CDMO Following Acquisition by Madison Dearborn Partners

SCIENTIST SPOTLIGHT: May 2018

Beyond the Bench: A Century of Experience

Elevate Product Stewardship and Exceed Your Sustainability Goals

Alcami St. Louis Facility to be Honored by Missouri House of Representatives and City of St. Louis

Case Study: Orphan Drug Product

SCIENTIST SPOTLIGHT: April 2018

Understanding Pharmaceutical Packaging

SCIENTIST SPOTLIGHT: March 2018

Panel Discussion: Oral Solid Dosage Manufacturing Process 

Editorial: Driving Change in the Pharma Industry and Biotech One Relationship at a Time

Editorial: Is Industry Ready for the Serialisation Shake-Up?

Alcami Donation to Outfit TROSA Medical Department

Editorial: Transparent and Timely Testing

Alcami Supports STEM Education at Local High School

SCIENTIST SPOTLIGHT: February 2018

Serialization CDMO Checklist

Editorial: Stability Testing Ensures Proper Packaging for Drug Storage

Editorial: Tackling the Opioid Crisis with Abuse-Deterrent Formulations

Stability: Back to the Basics - Part V

SCIENTIST SPOTLIGHT: January 2018

Beyond the Bench: Analytical Development and Professional Growth

Editorial: Analytical Testing - Contractors Take on the Challenge of Complex Molecules

SCIENTIST SPOTLIGHT: December 2017

Stability: Back to the Basics - Part IV

Alcami Helps Fight Opioid Addiction Epidemic

SCIENTIST SPOTLIGHT: November 2017

ON-DEMAND WEBINAR: Abuse-Deterrent Category One Testing: Syringeability Studies

Stability: Back to the Basics - Part III

Alcami Awarded Prosperity Prize at Business Ready Wisconsin Conference

Abuse-Deterrent Studies – An Interview with Angela Moore

Alcami Announces Manufacturing Agreement for Solasia’s Active Pharmaceutical Ingredient Darinaparsin

Editorial: Right-First-Time Innovation Approach Drives Continual Investment

Filter Validation – An Interview with Stacey Ramsey

Alcami Wins Prestigious Business of the Year Award from St. Louis Mayor

SCIENTIST SPOTLIGHT: October 2017

8 Characteristics of a State-of-the-Art Highly Potent API Facility

Alcami Technical Evaluations Specialist Speaks at University of Wisconsin-Washington County STEM Club

Stability: Back to the Basics - Part II

ON-DEMAND WEBINAR: Approach to HPAPI Suite Design in a Multi-Use Facility

Have a Highly Potent API? Here's What You Need to Consider

SCIENTIST SPOTLIGHT: September 2017

Editorial: Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations

Stability: Back to the Basics - Part I

At-A-Glance: Highly Potent API

Alcami Announces Grand Opening of St. Louis, Missouri Facility in Cortex Innovation Community

Alcami to Establish Active Pharmaceutical Ingredient Center of Excellence in Germantown, Wisconsin

Framework to Biologics – Part Three

SCIENTIST SPOTLIGHT: August 2017

Framework to Biologics – Part Two

Pitfalls of a Non-Integrated Drug Development Process

Framework to Biologics – A Three Part Series

SCIENTIST SPOTLIGHT: July 2017

Alcami Corporation and the University of North Carolina Wilmington Announce Academic Partnership

Video: Charleston Regional Development Alliance Features Alcami

Editorial: Oral Solid Dosage Manufacturing Roundtable

Editorial: Implications of Serialization for the U.S. Pharma Industry

Alcami Awarded for 2016 Manufacturing and Laboratories Operations Performance

SCIENTIST SPOTLIGHT: June 2017

Alcami Partners with Wisconsin Department of Natural Resources to Rebuild Kettle Moraine State Forest Trail

In-Use Stability Testing: Providing the Right Instructions

Serialization - Data Management Challenges

Limited Lab Capacity? An Extended Workbench Program can help

FAQs on What Happens If You Miss the Serialization Deadline

Alcami Participates in WILMA Dash and Health Fest

St. Louis Relocation Newsletter #3

Extractables and Leachables – Why?

Serialization Overview: What’s Required for November 27, 2017 Deadline

Alcami Participating in Upcoming STEAM Train Express

Bringing the Light to Photostability in Three Parts - Part Three

Bringing the Light to Photostability in Three Parts - Part Two

Alcami Announces Extended Workbench Offering for Analytical Services

Editorial: Formulation Development & Manufacturing — CDMOs Offer Speed, Advanced Technologies, & the Ability to Handle More Potent APIs

Bringing the Light to Photostability in Three Parts

Elemental Impurities – Highlights of the Coming Regulation

Editorial: Alcami Featured in Pharma Horizon's January 2017 Issue

SCIENTIST SPOTLIGHT: March 2017

Alcami in Action: 2016 in Review

Antibiotic Potency Testing: The Methods - Part 2

Antibiotic Potency Testing: The Methods – Part 1

SCIENTIST SPOTLIGHT: February 2017

Need to Know: Details About Alcami's New St. Louis, MO Facility

Elemental Impurities: The Risk-Based Approach

Overview and Performance of the Risk Evaluation and Mitigation Strategy (REMS) for Extended-Release (ER) and Long-Acting (LA) Opioid Analgesics

Battling the Opioid Abuse Epidemic - Top 10 Important Guidances and Resources

The Effect of Abuse-Deterrent Formulations on Opioid Abuse

Elemental Impurities: Updated Regulatory Requirements

Editorial: Analytical Testing: Market Drivers, Growing Demand & Client Needs

Have you Heard? Alcami’s St. Louis, MO Site is Moving!

Alcami Announces Completion of Site Investment and Expansion in Drug Product Manufacturing and Development Facilities

Alcami Announces New Highly Potent API Capabilities and Capacity in Germantown, WI

St. Louis Relocation Newsletter

St. Louis Relocation Regulatory Change Notification

Alcami Sponsors Employee Engagement Day at Students 2 Science

Quality and Regulatory Affairs Notification Letter

Alcami Announces Enhanced Laboratory Services in Wilmington, NC Headquarters

Alcami Invests in MicroSEQ® Rapid Microbial Identification System to Expand its Service Capabilities at Four U.S. Sites

Rigorous Integration in a Scalable Development and Manufacturing Enterprise to Support Continued Growth of Biopharmaceuticals

AAI Pharma Services Corporation And Cambridge Major Laboratories, Inc. Are Now Alcami